Labcorp to Announce Second Quarter Financial Results on August 1, 2024
Labcorp to Announce Second Quarter Financial Results on August 1, 2024
BURLINGTON, N.C., July 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2024 before the market opens on Thursday, August 1, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
北卡羅來納州伯靈頓，2024年7月1日 /PRNewswire/ — 創新和綜合實驗室服務的全球領導者Labcorp（紐約證券交易所代碼：LH）將在2024年8月1日星期四開市前發佈其2024年第二季度的財務業績。該公司將在美國東部時間當天上午9點開始舉行電話會議和網絡直播，討論結果。收益新聞稿和隨附的財務信息將在Labcorp投資者關係網站上發佈。
The call will be webcast live on the Labcorp Investor Relations website. Participants may also register for the call by clicking on this link, to receive the dial-in numbers and unique PIN to access the call. The webcast and dial-in are listen-only. It is recommended that participants join 10 minutes prior to the start, although participants may register and join at any time during the call.
電話會議將在Labcorp投資者關係網站上進行網絡直播。參與者還可以通過單擊此鏈接註冊通話，以接收撥入號碼和訪問通話的唯一 PIN。網絡直播和撥入僅限收聽。儘管參與者可以在通話期間隨時註冊和加入，但建議參與者在開始前10分鐘加入。
A replay of the webcast will be available approximately two hours after the conclusion of the live event and will be available until July 18, 2025. To access the webcast recording, visit the Labcorp Investor Relations website.
網絡直播的重播將在直播結束大約兩小時後播出，並將持續到2025年7月18日。要訪問網絡直播錄像，請訪問Labcorp投資者關係網站。
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at .
關於 Labcorp
Labcorp（紐約證券交易所代碼：LH）是創新和全面實驗室服務的全球領導者，可幫助醫生、醫院、製藥公司、研究人員和患者做出明確、自信的決策。我們通過無與倫比的診斷和藥物研發實驗室能力提供見解和推動科學發展，以改善健康狀況和改善生活。該公司的67,000多名員工爲約100個國家的客戶提供服務，爲美國食品藥品管理局於2023年批准的新藥和治療產品中的84％提供了支持，併爲全球患者進行了超過6億次測試。要了解有關我們的更多信息，請訪問。
SOURCE Labcorp Holdings Inc
來源 Labcorp 控股公司
譯文內容由第三人軟體翻譯。